Immunization and Immunological Testing: Principles and Applications

Immunization: Historical Perspectives and Principles

Glimpse of History: Early Immunization Practices

Immunization has a long history, with early practices predating the understanding of microbes as disease agents. The process of variolation, described in ancient Chinese writings, involved exposing individuals to material from smallpox lesions to induce immunity.

• Variolation: The deliberate exposure to powdered scabs from smallpox lesions, either inhaled or placed in the skin, to produce a mild disease and subsequent immunity.

• Risks: Occasionally fatal and contagious; practiced in China and the Middle East over a thousand years ago.

• Spread to Europe: Lady Mary Wortley Montagu introduced the practice to Europe after having her children immunized in Turkey. Despite its benefits, dangers and costs limited widespread adoption.

Development of Vaccination

• Edward Jenner: Observed that milkmaids who recovered from cowpox rarely contracted smallpox. In 1796, he inoculated James Phipps with cowpox material, and later exposed him to smallpox; Phipps did not develop the disease, demonstrating immunity.

• Vaccination: Louis Pasteur later coined the term to describe protective inoculation. The use of cowpox material was safer than smallpox variolation.

• Eradication Efforts: The World Health Organization (WHO) initiated a global smallpox vaccination campaign in 1967. With no animal hosts and effective immunization, the last natural case occurred in Somalia in 1977.

Principles of Immunization

Types of Immunity

Immunity can be acquired naturally or artificially, and can be classified as active or passive.

• Active Immunity: Results from exposure to an antigen, either through natural infection or artificial immunization. It leads to the production of memory cells and long-lasting protection.

• Passive Immunity: Involves the transfer of antibodies from another individual. It can be natural (e.g., maternal IgG crossing the placenta, IgA in breast milk) or artificial (e.g., injection of antiserum). Passive immunity provides immediate, but temporary, protection as no memory cells are produced.

Vaccines and Immunization Procedures

Vaccine Types and Herd Immunity

Vaccines are preparations of pathogens or their products used to induce active immunity. They protect individuals and contribute to herd immunity, which occurs when a critical portion of the population is immune, limiting disease spread.

• Attenuated Vaccines: Contain weakened forms of the pathogen that replicate in the recipient, usually causing no or mild disease. They elicit strong, long-lasting immunity but may pose risks to immunocompromised individuals and require refrigeration.

• Inactivated Vaccines: Contain killed microorganisms or inactivated viruses. They cannot replicate or cause disease, but often require booster doses and may include adjuvants to enhance the immune response.

Comparison of Attenuated and Inactivated Vaccines

Characteristic	Attenuated Vaccines	Inactivated Vaccines
Immune Response	Strong, long-lasting	Weaker, often requires boosters
Risk of Disease	Possible in immunocompromised	None
Stability	Requires refrigeration	More stable
Examples	MMR, Sabin polio, varicella	Influenza, Salk polio, rabies

Types of Inactivated Vaccines

• Inactivated Whole Agent Vaccines: Contain killed pathogens (e.g., influenza, rabies, Salk polio).

• Toxoids: Inactivated toxins retaining antigenicity (e.g., diphtheria, tetanus).

• Subunit Vaccines: Contain key antigens or fragments (e.g., acellular pertussis).

• Recombinant Vaccines: Produced by genetically engineered organisms (e.g., hepatitis B).

• VLP (Virus-Like Particle) Vaccines: Empty capsids produced by genetic engineering (e.g., HPV).

• Polysaccharide Vaccines: Made from bacterial capsules; less effective in young children (e.g., pneumococcus).

• Conjugate Vaccines: Polysaccharides linked to proteins to enhance response (e.g., Hib, Streptococcus pneumoniae).

Case Study: Polio Vaccination

• Salk Vaccine: Inactivated, requires injections, effective but less mucosal immunity.

• Sabin Vaccine: Oral, attenuated, induces strong mucosal (IgA) immunity and better herd immunity, but rare risk of vaccine-derived disease.

• Eradication Efforts: Combined use led to elimination of wild-type polio in the US by 1980 and in the Western Hemisphere by 1991. Global eradication efforts continue.

Importance of Childhood Immunizations

• Vaccines have dramatically reduced deaths and disabilities from infectious diseases.

• Vaccine hesitancy can lead to outbreaks, as seen with measles and pertussis.

• Benefits of vaccination far outweigh the minimal risks; no evidence links vaccines to autism.

Current Progress in Immunization

• Development of safer, more effective vaccines (e.g., conjugate vaccines, new adjuvants).

• Novel approaches: peptide vaccines, edible vaccines (antigen genes in plants), DNA-based vaccines.

Immunological Testing

Principles and Applications

Immunoassays utilize the specificity of antibody-antigen interactions for diagnostic purposes, such as detecting pathogens or immune responses in patients.

• Serology: The study of in vitro antibody-antigen interactions using serum or other body fluids.

• Seronegative: No specific antibodies detected; individual not yet exposed.

• Seropositive: Specific antibodies present; indicates exposure or infection.

• Seroconversion: The process of developing detectable antibodies, typically within 7-10 days after exposure.

Antibody Production

• Polyclonal Antibodies: Produced by immunizing animals with antigens; result in a mixture of antibodies recognizing multiple epitopes.

• Monoclonal Antibodies: Produced by fusing B cells with myeloma cells to create hybridomas; recognize a single epitope, can be "humanized" for therapeutic use.

Quantifying Antigen-Antibody Reactions

• Titer: Determined by serial dilution; the highest dilution showing a positive reaction indicates antibody concentration.

• Commonly performed in microtiter plates with multiple wells.

Observing Antigen-Antibody Aggregation

• Precipitation Reactions: Antibodies cross-link soluble antigens to form a visible precipitate, optimal at certain concentrations (zone of equivalence).

• Ouchterlony Technique: An immunodiffusion test in gel to visualize precipitation lines.

• Agglutination Reactions: Involve larger, insoluble particles (e.g., cells, beads); direct agglutination is used in blood typing, passive agglutination uses coated particles for detection.

Using Labeled Antibodies to Detect Antigen-Antibody Interactions

• Direct Tests: Detect unknown antigens using labeled antibodies.

• Indirect Tests: Detect patient antibodies using known antigens and labeled secondary antibodies.

• Fluorescent Antibody (FA) Tests: Use fluorescence microscopy to locate labeled antibodies bound to antigens.

• Enzyme-Linked Immunosorbent Assay (ELISA): Uses enzyme-labeled antibodies and colorimetric detection; direct ELISA detects antigens, indirect ELISA detects antibodies (e.g., HIV screening).

• Western Blotting: Proteins separated by SDS-PAGE, transferred to a membrane, and detected with labeled antibodies; used to confirm ELISA results.

• Fluorescence-Activated Cell Sorter (FACS): A flow cytometry technique to count and separate cells labeled with fluorescent antibodies (e.g., CD4 and CD8 T cell subsets).

Additional info: The notes above expand on brief points from the slides, providing definitions, examples, and context for key immunological concepts and laboratory techniques relevant to microbiology students.